CareClix Holdings, Inc. Research and Development Expense
CareClix Holdings, Inc. reported Research and Development Expense of $510.50 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-02-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-02-16
- CareClix Holdings, Inc. research and development expense for the quarter ending 2019-09-30 was $1.74K, a 8580.00% increase year-over-year.
- CareClix Holdings, Inc. research and development expense for the quarter ending 2019-06-30 was $0.00.
- CareClix Holdings, Inc. research and development expense for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- CareClix Holdings, Inc. research and development expense for the quarter ending 2018-09-30 was $20.00.
- CareClix Holdings, Inc. research and development expense for fiscal 2019 was $510.50K.
- CareClix Holdings, Inc. research and development expense for fiscal 2018 was $0.00.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $510.50K 10-K · filed 2021-02-16 | |||
| 2019-09-30 | $1.74K 10-Q · filed 2019-11-25 | $1.74K derived: sum of 2 quarters · filed 2019-11-25 | $1.74K derived: sum of 3 quarters · filed 2019-11-25 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-09-12 | $0.00 10-Q · filed 2019-09-12 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-20 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-16 | |||
| 2018-09-30 | $20.00 10-Q · filed 2019-11-25 | $20.00 derived: sum of 2 quarters · filed 2019-11-25 | $40.00 derived: sum of 3 quarters · filed 2019-11-25 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-09-12 | $20.00 10-Q · filed 2019-09-12 | ||
| 2018-03-31 | $20.00 10-Q · filed 2019-05-20 |